Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Via Amendola 2, 42122, Reggio Emilia, MD, Italy.
Medical Oncology, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, MD, Italy.
BMC Public Health. 2021 May 12;21(1):906. doi: 10.1186/s12889-021-10746-4.
Right-sided colorectal cancer (CRC) has worse survival than does left-sided CRC. The objective of this study was to further assess the impact of right-side location on survival and the role of the extent of lymphadenectomy.
All CRCs diagnosed between 2000 and 2012 in Emilia-Romagna Region, Italy, were included. Data for stage, grade, histology, screening history, and number of removed lymph nodes (LN) were collected. Multivariable Cox regression models were used to estimate hazard ratios (HR), with relative 95% confidence intervals (95%CI), of right vs. left colon and of removing < 12, 12-21 or > 21 lymph nodes by cancer site.
During the study period, 29,358 patients were registered (8828 right colon, 18,852 left colon, 1678 transverse). Patients with right cancer were more often older, females, with advanced stage and high grade, and higher number of removed LNs. Five-year survival was lower in the right than in the left colon (55.2% vs 59.7%). In multivariable analysis, right colon showed a lower survival when adjusting for age, sex, and screening status (HR 1.12, 95%CI 1.04-1.21). Stratification by number of lymph nodes removed (12-21 or > 21) was associated with better survival in right colon (HR 0.54, 95%CI 0.40-0.72 and HR 0.40, 95%CI 0.30-0.55, respectively) compared to left colon (HR 0.89, 95%CI 0.76-1.06 and HR 0.83, 95%CI 0.69-1.01, respectively).
This study confirms that right CRC has worse survival; the association is not due to screening status. An adequate removal of lymph nodes is associated with better survival, although the direction of the association in terms of causal links is not clear.
右侧结直肠癌(CRC)的生存情况不如左侧 CRC。本研究的目的是进一步评估右侧位置对生存的影响以及淋巴结清扫范围的作用。
纳入 2000 年至 2012 年间在意大利艾米利亚-罗马涅地区诊断的所有 CRC 患者。收集了分期、分级、组织学、筛查史和切除的淋巴结(LN)数量等数据。采用多变量 Cox 回归模型估计右侧 vs. 左侧结肠癌和根据肿瘤部位切除<12、12-21 或>21 个淋巴结的危险比(HR),并计算相对 95%置信区间(95%CI)。
在研究期间,共登记了 29358 例患者(右侧结肠癌 8828 例,左侧结肠癌 18852 例,横结肠癌 1678 例)。右侧癌症患者通常年龄较大,女性,分期较晚,分级较高,切除的 LN 数量也较多。右侧结肠癌的 5 年生存率低于左侧结肠癌(55.2% vs 59.7%)。在多变量分析中,右侧结肠癌在调整年龄、性别和筛查状态后,生存率较低(HR 1.12,95%CI 1.04-1.21)。根据切除的淋巴结数量(12-21 个或>21 个)进行分层,与左侧结肠癌相比,右侧结肠癌的生存情况更好(HR 0.54,95%CI 0.40-0.72 和 HR 0.40,95%CI 0.30-0.55),而左侧结肠癌的生存情况则更差(HR 0.89,95%CI 0.76-1.06 和 HR 0.83,95%CI 0.69-1.01)。
本研究证实右侧 CRC 的生存情况较差;这种关联不是由于筛查状态所致。充分的淋巴结清扫与生存情况改善有关,尽管因果关系的方向尚不清楚。